Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc. GILD gained following the earnings beat and upbeat guidance for 2025, ...

Biotech and drug stocks, collectively, are down an average of 16% over the past three months. The closely watched XBI index ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Hyderabad's commercial real estate market booming, driven by technology sector, skilled talent pool, and growing Global Capability Centers.

According to a report by CBRE South Asia Pvt Ltd and HYSEA, the city's office stock has more than tripled since 2014, ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio’s leadership believes that ...